Mylan NV on Monday officially took its takeover bid directly to shareholders of Perrigo Co. (PRGO 0.88 %) after the company’s board and management publicly rebuffed previous advances.   Mylan is […]

HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (NYSE: RDY) today announced the signing of a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative prescription head lice product, Xeglyze™ Lotion. […]

Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave […]

Takeda Pharmaceutical Company, headquartered in Osaka, Japan, and Charlottesville, Va.-based Gencia LLC announced today a $500 million partnership deal. The two companies plan to work on a new class of […]

MELBOURNE, Australia— AstraZeneca PLC[2] (AZN[3]) struck a deal worth up to $450 million with Australia-based Starpharma[4] to license that company’s DEP drug delivery platform for use with its oncology medications. […]

Lannett Company Inc. has agreed to buy UCB SA’s Kremers Urban Pharmaceuticals Inc. for $1.23 billion. The deal, with tax benefits expected to top $100 million, also calls for potential […]

Paris-based Sanofi (SNY) announced yesterday that it was terminating its option and license agreement with Fremont, Calif.-based Ardelyx (ARDX) for its NaP2b inhibitors. The termination will go into effect Sept. […]

GOTEBORG, Sweden — Could Meda AB be selling off its U.S. operations? Some sources are suggesting a deal could be in the works. Late Thursday, Bloomberg Business, citing “people familiar […]

Hepalink USA, the wholly owned U.S. subsidiary of Shenzhen Hepalink Pharmaceutical, will acquire the biopharmaceutical contract development manufacturing organization Cytovance® Biologics for $205.68 million cash plus additional contingent payments, Cytovance […]

San Francisco-based Medivation, Inc. (MDVN), and San Rafael, Calif.-based BioMarin Pharmaceutical Inc. (BMRN) announced today that they have signed a deal for Medivation to buy all worldwide rights to talazoparib, […]